1.
Abualsaud MA, AlAwami FA, Algashaneen HMA, Albelushi NA, Alyami AS, ALNasseri MA, et al. Tirzepatide in Type 2 Diabetes Mellitus: A Comprehensive Review of Its Novel Dual GIP/GLP-1 Receptor Agonism, Clinical Efficacy, Safety, and Therapeutic Potential. IJASIS [Internet]. 2026 Oct. 8 [cited 2026 Oct. 25];:31-9. Available from: https://xlescience.org/index.php/IJASIS/article/view/2213